• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大型欧洲队列中晚发性亨廷顿病的临床和遗传特征。

Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.

机构信息

Movement Disorders Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Department of Psychology, Università Cattolica del Sacro Cuore, Milan, Italy.

出版信息

Eur J Neurol. 2022 Jul;29(7):1940-1951. doi: 10.1111/ene.15340. Epub 2022 Apr 17.

DOI:10.1111/ene.15340
PMID:35357736
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9324106/
Abstract

BACKGROUND AND PURPOSE

Huntington's disease (HD) is an autosomal dominant condition caused by CAG-triplet repeat expansions. CAG-triplet repeat expansion is inversely correlated with age of onset in HD and largely determines the clinical features. The aim of this study was to examine the phenotypic and genotypic correlates of late-onset HD (LoHD) and to determine whether LoHD is a more benign expression of HD.

METHODS

This was a retrospective observational study of 5053 White European HD patients from the ENROLL-HD database. Sociodemographic, genetic and phenotypic variables at baseline evaluation of subjects with LoHD, common-onset HD (CoHD) and young-onset HD (YoHD) were compared. LoHD subjects were compared with healthy subjects (HS) aged ≥60 years. Differences between the CoHD and LoHD groups were also explored in subjects with 41 CAG triplets, a repeat number in the lower pathological expansion range associated with wide variability in age at onset.

RESULTS

Late-onset HD presented predominantly as motor-onset disease, with a lower prevalence of both psychiatric history and current symptomatology. Absent/unknown HD family history was significantly more common in the LoHD group (31.2%) than in the other groups. The LoHD group had more severe motor and cognitive deficits than the HS group. Subjects with LoHD and CoHD with 41 triplets in the larger allele were comparable with regard to cognitive impairment, but those with LoHD had more severe motor disorders, less problematic behaviors and more often an unknown HD family history.

CONCLUSIONS

It is likely that cognitive disorders and motor symptoms of LoHD are at least partly age-related and not a direct expression of the disease. In addition to CAG-triplet repeat expansion, future studies should investigate the role of other genetic and environmental factors in determining age of onset.

摘要

背景与目的

亨廷顿病(HD)是一种常染色体显性疾病,由 CAG-三核苷酸重复扩展引起。CAG-三核苷酸重复扩展与 HD 的发病年龄呈负相关,在很大程度上决定了临床特征。本研究旨在探讨迟发性 HD(LoHD)的表型和基因型相关性,并确定 LoHD 是否是 HD 的一种更为良性的表现。

方法

这是一项对 ENROLL-HD 数据库中 5053 名白种欧洲 HD 患者的回顾性观察性研究。对 LoHD、共同发病 HD(CoHD)和早发 HD(YoHD)患者的基线评估时的社会人口统计学、遗传和表型变量进行了比较。将 LoHD 患者与≥60 岁的健康对照者(HS)进行比较。还在 41 个 CAG 三核苷酸重复的患者中探讨了 CoHD 和 LoHD 组之间的差异,该重复数处于较低的病理扩展范围,与发病年龄的广泛变异性相关。

结果

迟发性 HD 主要表现为运动起始疾病,精神病病史和当前症状的发生率均较低。未知/未知 HD 家族史在 LoHD 组(31.2%)中明显比其他组更为常见。与 HS 组相比,LoHD 组的运动和认知缺陷更为严重。具有 LoHD 和 CoHD 且较大等位基因中具有 41 个三核苷酸重复的患者在认知障碍方面相当,但 LoHD 患者的运动障碍更严重,行为问题较少,且经常具有未知的 HD 家族史。

结论

LoHD 的认知障碍和运动症状可能至少部分是与年龄相关的,而不是疾病的直接表现。除 CAG-三核苷酸重复扩展外,未来的研究还应探讨其他遗传和环境因素在确定发病年龄中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df6/9324106/f7f9954d755a/ENE-29-1940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df6/9324106/6962a0869c1c/ENE-29-1940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df6/9324106/f7f9954d755a/ENE-29-1940-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df6/9324106/6962a0869c1c/ENE-29-1940-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2df6/9324106/f7f9954d755a/ENE-29-1940-g001.jpg

相似文献

1
Clinical and genetic characteristics of late-onset Huntington's disease in a large European cohort.大型欧洲队列中晚发性亨廷顿病的临床和遗传特征。
Eur J Neurol. 2022 Jul;29(7):1940-1951. doi: 10.1111/ene.15340. Epub 2022 Apr 17.
2
Late-onset Huntington disease: An Italian cohort.迟发性亨廷顿病:一项意大利队列研究。
J Clin Neurosci. 2021 Apr;86:58-63. doi: 10.1016/j.jocn.2020.12.025. Epub 2021 Jan 27.
3
What do we know about Late Onset Huntington's Disease?我们对迟发性亨廷顿舞蹈症了解多少?
J Huntingtons Dis. 2017;6(2):95-103. doi: 10.3233/JHD-170247.
4
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.超越 CAG 三联体数:探索亨廷顿病发病年龄延迟的潜在预测因素。
J Neurol. 2022 Dec;269(12):6634-6640. doi: 10.1007/s00415-022-11297-3. Epub 2022 Aug 1.
5
Comparison of mid-age-onset and late-onset Huntington's disease in Finnish patients.芬兰患者中年发病与晚发亨廷顿病的比较。
J Neurol. 2017 Oct;264(10):2095-2100. doi: 10.1007/s00415-017-8600-2. Epub 2017 Aug 28.
6
Clinical and Genetic Characteristics Associated With Survival Outcome in Late-Onset Huntington's Disease in South Korea.韩国晚发性亨廷顿舞蹈病生存结局相关的临床与遗传学特征
J Clin Neurol. 2024 Jul;20(4):394-401. doi: 10.3988/jcn.2023.0329. Epub 2024 Apr 2.
7
Huntington's Disease: Relationship Between Phenotype and Genotype.亨廷顿舞蹈症:表型与基因型之间的关系
Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7.
8
Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.迟发性与成年发病型亨廷顿病患者的医疗资源利用和成本:一项基于理赔的回顾性队列研究。
J Med Econ. 2023 Jan-Dec;26(1):862-870. doi: 10.1080/13696998.2023.2228166.
9
The Clinical Features and Progression of Late-Onset Versus Younger-Onset in an Adult Cohort of Huntington's Disease Patients.成年亨廷顿病患者中晚发型与早发型的临床特征和进展。
J Huntingtons Dis. 2020;9(3):275-282. doi: 10.3233/JHD-200404.
10
The Impact of Family History on the Clinical Features of Huntington's Disease.家族史对亨廷顿舞蹈病临床特征的影响
J Huntingtons Dis. 2017;6(4):327-335. doi: 10.3233/JHD-170256.

引用本文的文献

1
Significant underascertainment in Huntington's disease.亨廷顿舞蹈症存在显著的确诊不足情况。
Brain Commun. 2025 May 20;7(3):fcaf194. doi: 10.1093/braincomms/fcaf194. eCollection 2025.
2
Mitochondrial DNA editing: Key to the treatment of neurodegenerative diseases.线粒体DNA编辑:治疗神经退行性疾病的关键。
Genes Dis. 2024 Sep 21;12(4):101437. doi: 10.1016/j.gendis.2024.101437. eCollection 2025 Jul.
3
Social cognition in basal ganglia pathologies: Theory of Mind in Huntington's and Parkinson's diseases.基底神经节病变中的社会认知:亨廷顿舞蹈症和帕金森病中的心理理论

本文引用的文献

1
The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration.衰老的大脑:神经退行性变的分子与细胞基础
Front Cell Dev Biol. 2021 Aug 13;9:683459. doi: 10.3389/fcell.2021.683459. eCollection 2021.
2
Huntington's disease: nearly four decades of human molecular genetics.亨廷顿病:近四十年的人类分子遗传学研究。
Hum Mol Genet. 2021 Oct 1;30(R2):R254-R263. doi: 10.1093/hmg/ddab170.
3
Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis.亨廷顿病发病年龄和行为表现:Enroll-HD 队列分析。
Soc Cogn Affect Neurosci. 2025 Feb 20;20(1). doi: 10.1093/scan/nsaf007.
4
A Practical Guide for Diagnostic Investigations and Special Considerations in Patients With Huntington's Disease in Korea.韩国亨廷顿舞蹈症患者诊断检查及特殊注意事项实用指南。
J Mov Disord. 2025 Jan;18(1):17-30. doi: 10.14802/jmd.24232. Epub 2024 Dec 26.
5
Emerging trends in cognitive impairment and dementia among older populations in Asia: A systematic review.亚洲老年人群认知障碍和痴呆症的新趋势:系统综述。
J Glob Health. 2024 Nov 8;14:04233. doi: 10.7189/jogh.14.04233.
6
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease.超越 CAG 三联体数:探索亨廷顿病发病年龄延迟的潜在预测因素。
J Neurol. 2022 Dec;269(12):6634-6640. doi: 10.1007/s00415-022-11297-3. Epub 2022 Aug 1.
Clin Genet. 2021 Jan;99(1):133-142. doi: 10.1111/cge.13857. Epub 2020 Oct 16.
4
Influence of Age of Onset on Huntington's Disease Phenotype.发病年龄对亨廷顿病表型的影响。
Tremor Other Hyperkinet Mov (N Y). 2020 Jul 9;10:21. doi: 10.5334/tohm.536.
5
Improvements to Healthspan Through Environmental Enrichment and Lifestyle Interventions: Where Are We Now?通过环境富集和生活方式干预改善健康寿命:我们目前的进展如何?
Front Neurosci. 2020 Jun 12;14:605. doi: 10.3389/fnins.2020.00605. eCollection 2020.
6
Genetic and Functional Analyses Point to FAN1 as the Source of Multiple Huntington Disease Modifier Effects.遗传和功能分析表明 FAN1 是多种亨廷顿病修饰效应的来源。
Am J Hum Genet. 2020 Jul 2;107(1):96-110. doi: 10.1016/j.ajhg.2020.05.012. Epub 2020 Jun 25.
7
Biological Aging and the Cellular Pathogenesis of Huntington's Disease.生物衰老与亨廷顿病的细胞发病机制。
J Huntingtons Dis. 2020;9(2):115-128. doi: 10.3233/JHD-200395.
8
Late-onset Huntington's disease with 40-42 CAG expansion.具有40 - 42个CAG重复序列扩增的迟发性亨廷顿舞蹈病。
Neurol Sci. 2020 Apr;41(4):869-876. doi: 10.1007/s10072-019-04177-8. Epub 2019 Dec 9.
9
CAG Repeat Not Polyglutamine Length Determines Timing of Huntington's Disease Onset.CAG 重复序列而非多聚谷氨酰胺长度决定亨廷顿病发病时间。
Cell. 2019 Aug 8;178(4):887-900.e14. doi: 10.1016/j.cell.2019.06.036.
10
Clinical and genetic characteristics of late-onset Huntington's disease.迟发性亨廷顿病的临床和遗传特征。
Parkinsonism Relat Disord. 2019 Apr;61:101-105. doi: 10.1016/j.parkreldis.2018.11.009. Epub 2018 Nov 29.